About Regional Oncology Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Genentech, Inc.
1
Clinical Trials at Regional Oncology Center
During the past decade, Regional Oncology Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
2012-01-20
2016-03-30
Completed
501
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
2012-08-24
2016-09-16
Completed
572
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Regional Oncology Center
According to Clinical.Site data, the most researched conditions in "Regional Oncology Center" are
"Lymphoma, Large B-Cell, Diffuse" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Regional Oncology Center" in a lesser frequency.
Clinical Trials Intervention Types at Regional Oncology Center
Most popular intervention types in "Regional Oncology Center" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "CHOP" (1 trials), "Chemotherapy (Induction Period)" (1 trials), "Placebo" (1 trials), "Rituximab" (1 trials) and "bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Regional Oncology Center
The vast majority of trials in "Regional Oncology Center" are
3 trials for "All" genders.
Clinical Trials Status at Regional Oncology Center
Currently, there are NaN active trials in "Regional Oncology Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Regional Oncology Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Regional Oncology Center, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".